Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that it has priced an offering of $2.5 billion aggregate principal amount (the “Offering”) of the following notes:$500 ...

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, today announced the pricing of an ...

OptymEdge hires Senior Director to Drive Global Roll-Out of ACUVERA PlatformROCKVILLE, MD,September 30th, 2025: ...

Healthcare delivery is undergoing a paradigm shift, and Ambulatory Surgical and Emergency Centers (ASECs) are central to that ...

In recent years, smart contact lenses have evolved into one of the most promising innovations at the intersection of wearable ...

Bringing a new therapy to market is one of the most complex challenges in the pharmaceutical industry. Success depends on ...

GSK CEO Dame Emma Walmsley will step down at the end of 2025 and be succeeded by Luke Miels, who will lead the company into a ...

Biocomputing sits at the frontier of technological innovation, using biological molecules, cells or tissues to carry out ...

High IL1RAP protein expression on tumor cells is linked to poor survival in PDAC patients treated with chemotherapy, while this patient group has the longest survival when treated with nadunolimab in ...

Precision Biologics Manufacturing breaks ground creating 200-300 jobs and expanding U.S.-based wound care manufacturing in 2026 HENDERSON, NV AND LAS VEGAS, NV / ACCESS Newswire / September 30, 2025 / ...

STOCKHOLM, SWEDEN / ACCESS Newswire / September 30, 2025 / iZafe Group (STO:IZAFE-B) today signed an agreement to acquire its exclusive distributor in the Netherlands, Thuisapparatuur Nederland B.V., ...

Zelasudil, a potential best-in-class, selective ROCK2 inhibitor shows evidence of anti-fibrotic activity at 12 and 24 weeks in patients with IPFZelasudil reduces FVC decline numerically at 12 weeks ...